AllianceBernstein’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-23,400	Closed	-$540K	–	3350
2020 Q4	$540K	Hold	23,400	–	–	﹤0.01%	2546
2020 Q3	$238K	Sell	23,400 -900	-4%	-$9.15K	﹤0.01%	2904
2020 Q2	$362K	Buy	24,300 +12,200	+101%	+$182K	﹤0.01%	2792
2020 Q1	$147K	Buy	+12,100	New	+$147K	﹤0.01%	2871